Previous 10 |
Inogen (NASDAQ: INGN ): Q3 GAAP EPS of $0.73 beats by $0.21 . Revenue of $95.3M (+38.1% Y/Y) beats by $4.35M . Shares -4.26% . Press Release More news on: Inogen, Inc, Earnings news and commentary, Healthcare stocks news,
- Q3 2018 Sales Revenue up 42.1% Over the Same Period in 2017 - - Provides Updated 2018 Guidance and Initial 2019 Guidance - Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported ...
ACAD , AAXN , AIZ , APEI , ASH , BEL , BOLD , BWXT , CHUY , COHR , CPE , CSLT , CUTR , CWH , DAR , DATA , DIOD , DK , DOOR , DPLO , DVN , DXC , DXCM , EGN , ENLC , ENLK , ENPH , ETSY , EVH , EVRI , FANG , FIVN , FTK , FTR , G , GDDY , GHDX , GLUU , HAL...
Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 2018 Stifel Healthcare Conference in New York City. Inogen’s Pr...
News, Short Squeeze, Breakout and More Instantly...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter 2024 financial results after the market closes on Tuesday, August 6, 2024. On the same day, the Company wil...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith jo...